Glycorex Transplantation Overview
- Founded
-
1996
- Status
-
Public
- Employees
-
22
- Stock Symbol
-
GTAB B
- Share Price
-
$0.40
- (As of Friday Closing)
Glycorex Transplantation General Information
Description
Glycorex Transplantation AB is a biotechnology company. The company is involved in the development, production, and sales of organ transplantation. Its product includes Glycosorb-ABO which facilitates the transplantation of organs over the blood group barriers. The group has more than 130 transplant centers in approximately 23 countries.
Contact Information
Primary Industry
Other Devices and Supplies
Other Industries
Biotechnology
Stock Exchange
NGM
Primary Office
- Scheelevägen 27
- 223 63 Lund
- Sweden
+46 046-286 00 00
Glycorex Transplantation Stock Performance
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $0.40 | $0.40 | $0.36 - $1.17 | $29.8M | 73.9M | 33.6K | -$0.02 |
Glycorex Transplantation Financials Summary
|
In Thousands, USD |
TTM 30-Jun-2022 | FY 2021 31-Dec-2021 | FY 2020 31-Dec-2020 | FY 2019 31-Dec-2019 |
|---|---|---|---|---|
| EV | 41,227 | 71,996 | 99,022 | 77,351 |
| Revenue | 3,629 | 3,284 | 2,928 | 3,817 |
| EBITDA | (175) | (405) | (57) | 1,310 |
| Net Income | (1,133) | (1,426) | (872) | 730 |
| Total Assets | 9,298 | 11,249 | 13,738 | 9,181 |
| Total Debt | 786 | 1,000 | 1,139 | 1,532 |
Public Fundamental Data provided by Morningstar, Inc.
disclaimer
Glycorex Transplantation Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Glycorex Transplantation Patents
Glycorex Transplantation Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-3762716-A4 | A protein-binding product, a device contaning said protein-binding product and a method for extracorporeal reduction of the level of protein in blood plasma | Pending | 08-Mar-2018 | 00000000000 | |
| EP-3762716-A1 | A protein-binding product, a device contaning said protein-binding product and a method for extracorporeal reduction of the level of protein in blood plasma | Pending | 08-Mar-2018 | 00000000000 | |
| US-20200406230-A1 | A protein-binding product, a device containing said protein-binding product and a method for extracorporeal reduction of the level of protein in blood plasma | Pending | 08-Mar-2018 | 00000000000 | |
| US-20140255409-A1 | Method for extracorporeal elimination of one or more components from blood | Inactive | 28-Oct-2011 | 00000000000 | |
| EP-2771087-A1 | A method for extracorporeal elimination of one or more components from blood | Inactive | 28-Oct-2011 | B01D15/3804 |
Glycorex Transplantation Executive Team (3)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Johan Nilsson | Interim Chief Executive Officer | ||
| Kurt Nilsson | Founder & Chairman |
Glycorex Transplantation Board Members (1)
| Name | Representing | Role | Since |
|---|---|---|---|
| 0000 0000000 | Glycorex Transplantation | Founder & Chairman | 000 0000 |
Glycorex Transplantation Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
